Stocks and Investing Stocks and Investing
Mon, December 20, 2021
Fri, December 17, 2021

Andrew Berens Maintained (ZNTL) at Buy with Increased Target to $97 on, Dec 17th, 2021


Published on 2024-10-27 19:02:40 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy with Increased Target from $89 to $97 on, Dec 17th, 2021.

Andrew has made no other calls on ZNTL in the last 4 months.



There are 4 other peers that have a rating on ZNTL. Out of the 4 peers that are also analyzing ZNTL, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Andrew


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $120 on, Thursday, November 11th, 2021
  • Robert Driscoll of "Wedbush" Maintained at Buy with Increased Target to $89 on, Wednesday, October 27th, 2021
  • Bradley Canino of "Stifel" Initiated at Strong Buy and Held Target at $84 on, Thursday, September 30th, 2021
  • Matthew Biegler of "Oppenheimer" Initiated at Buy and Held Target at $90 on, Wednesday, September 29th, 2021
Contributing Sources